Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer

European Urology, Supplements

Volumn 7, Issue 7, 2008, Pages 529-535

  Jichlinski, Patrice ^a   Jacqmin, Didier ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Austria   (Netherlands)

Author keywords

Bladder cancer; Blue light; Fluorescence; Hexaminolevulinate; Photodynamic diagnosis (PDD); Sensitivity

Indexed keywords

AMINOLEVULINIC ACID; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN;

BIOMEDICAL TECHNOLOGY ASSESSMENT; BLADDER CANCER; BLUE LIGHT; CANCER DIAGNOSIS; CARCINOMA IN SITU; CYSTOSCOPY; DIAGNOSTIC ACCURACY; FLUORESCENCE; HUMAN; PHOTODYNAMICS; PRIORITY JOURNAL; REVIEW;

EID: 43849099078     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2008.04.004     Document Type: Review

References (36)

1. Jones P.A., and Droller M.J. Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms. Semin Urol 11 (1993) 177-192
2. Brausi M., Collette L., Kurth K., et al. Variability in recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41 (2002) 523-531
3. Parmar M.K.B., Friedman L.S., Hargreavs T.B., et al. Prognostic factors for recurrence. Follow-up policies in the treatment of superficial bladder cancer. Report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol 142 (1989) 284-288
4. Van der Meijden A.P.M., Sylvester R., Oosterlink W., et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 48 (2005) 363-371
5. Fradet Y., Loskart C., and the ImmunoCyt trialists. Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt. Can J Urol 3 (1997) 400-405
6. Bubendorf L., Grilli B., Sauter G., et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116 (2001) 79-86
7. Rathert P., and Roth S. Indications for urinary cytology. In: Rather P., Roth S., and Soloway M.S. (Eds). Urinary Cytology, Manual and Atlas. ed. 2 (1993), Springer-Verlag, New York, Berlin, Heidelberg 9-13
8. Harving N., Wolf H., and Melsen F. Positive urinary cytology after tumor resection: an indicator for concomitant carcinoma in situ. J Urol 140 (1988) 495-497
9. Bostwick D.G. Natural history of early bladder cancer. J Cell Biochem 161 (1992) 31-38
10. Frampton J.E., and Plosker G.L. Hexyl aminolevulinate in the detection of bladder cancer. Drugs 66 (2006) 571-578
11. Whitmore Jr. W.F., and Bush I.M. Ultraviolet cystoscopy. JAMA 203 (1968) 1057-1059
12. Barlow K.A., Maurice B.A., and Atkins P. Ultraviolet fluorescence of bladder tumors following oral administration of tetracycline compounds. A macroscopic, microscopic, and fluorescence spectrophotometric study. Cancer 19 (1966) 1013-1018
13. Kelly J.F. Haematoporphyrins in the diagnosis and treatment of carcinoma of the bladder. Proc R Soc Med 68 (1975) 527-528
14. Baumgartner R., Hofstetter A., Jocham D., Kriegmair M., Stepp H., and Unsöld E. Photodynamic diagnosis in urology-first clinical experiences with a new method for detection of early stage cancer. Lasermedizin (1992) 16-21
15. Jocham D., Baumgartner R., Fuchs N., Lenz H., Stepp H., and Unsöld E. Die Fluoreszenzdiagnose porphyrin-markierter urothelialer tumoren. Urologe A 28 (1989) 59-64
16. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6 (1990) 143-148
17. Lange N., Jichlinski P., Zellweger M., et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 80 (1999) 185-193
18. Kriegmair M., Baumgartner R., Knüchel R., et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44 (1994) 836-841
19. Jichlinski P., Forrer M., Mizeret J., et al. Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid. Lasers Surg Med 20 (1997) 402-408
20. Koenig F., McGovern F.J., Larne R., Enquist H., Schomacker K.T., and Deutsch T.F. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int 83 (1999) 129-135
21. Marti A., Lange N., van den Bergh H., et al. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol 162 (1999) 546-552
22. Jichlinski P., Guillou L., Karlsen S.J., et al. Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 170 (2003) 226-229
23. Schmidbauer J., Witjes F., Schmeller N., et al. Improved detection of rrothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 171 (2004) 135-138
24. Grossman H.B., Gomella L., Fradet Y., et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 178 (2007) 62-67
25. Fradet Y., Grossman H.B., Gomella L., et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white-light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 178 (2007) 68-73
26. Witjes J.A., Moonen P.M.J., and van der Heijden A.G. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective phase II study. Eur Urol 47 (2005) 319-322
27. Loidl W., Schmidbaur J., Susani M., and Marberger M. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?. Eur Urol 47 (2005) 323-326
28. Jocham D., Stepp H., and Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 53 (2008) 1138-1150
29. Jichlinski P., and Leisinger H.J. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist!. Urol Int 74 (2005) 97-101
30. Colapaoli L., Thorsen J., Nopp A., and Guttormsen A. A case of anaphylactic shock possibly caused by intravesical Hexvix. Acta Anaesthesiol Scand 50 (2006) 1165-1167
31. Sylvester R.J., van der Meijden A.P.M., Oosterlinck W., Witjes J.A., Bouffioux C., Denis L., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466-477
32. Zaak D., Hungerhuber E., Schneede P., Stepp H., Frimberger D., Corvin S., et al. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer 95 (2002) 1234-1238
33. Jocham D., Witjes F., Wagner S., Zeylemaker B., van Moorselaar J., Grimm M.O., et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 174 (2005) 862-866
34. Klän R., Loy V., and Huland H. Residual tumour discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146 (1991) 316-318
35. Grimbergen M.C.M., van Swol C.F.P., Jonges T.G.M., Boon T.A., and van Moorselaar R.J.A. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 44 (2003) 51-56
36. Schmidbauer J., Remzi M., Lindenau G., Susani M., and Marberger M. Optical coherence tomography and hexaminolevulinate fluorescence cystoscopy in detecting urothelial carcinoma of the bladder. Eur Urol Suppl 7 (2008) 77 (abstract no. 28)